Daniela M Dinulescu

Daniela M Dinulescu

UNVERIFIED PROFILE

Are you Daniela M Dinulescu?   Register this Author

Register author
Daniela M Dinulescu

Daniela M Dinulescu

Publications by authors named "Daniela M Dinulescu"

Are you Daniela M Dinulescu?   Register this Author

30Publications

914Reads

50Profile Views

Defining fallopian tube-derived miRNA cancer signatures.

Cancer Med 2019 Sep 10. Epub 2019 Sep 10.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2416DOI Listing
September 2019

Frontiers in the Pathology and Pathogenesis of Ovarian Cancer: Cancer Precursors and "Precursor Escape".

Hematol Oncol Clin North Am 2018 12;32(6):915-928

Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.07.013DOI Listing
December 2018

Origin of clear cell carcinoma: nature or nurture?

J Pathol 2018 Feb 2;244(2):131-134. Epub 2018 Jan 2.

Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5009DOI Listing
February 2018

Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma.

Oncotarget 2016 Oct;7(40):66077-66086

Department of Obstetrics/Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323216PMC
October 2016

The promise and challenge of ovarian cancer models.

Transl Cancer Res 2015 Feb;4(1):14-28

Department of Pathology, Division of Women's and Perinatal Pathology, Eugene Braunwald Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-676X.2015.01.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477961PMC
February 2015

Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.

Front Oncol 2014 18;4:322. Epub 2014 Nov 18.

Division of Women's and Perinatal Pathology, Department of Pathology, Eugene Braunwald Research Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235464PMC
December 2014

Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy.

Cancer Res 2013 Dec 11;73(23):6987-97. Epub 2013 Oct 11.

Authors' Affiliations: Laboratory for Nanomedicine, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital; Harvard-MIT Division of Health Sciences and Technology; Indo-US Joint Center for Nanobiotechnology, Cambridge; Department of Pathology, Brigham and Women's Hospital; Harvard Medical School, Boston; Dana Farber Cancer Institute, Brookline, Massachusetts; Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, San Diego; Center for Nanomedicine, Department of Cell, Molecular and Developmental Biology, University of California, Santa Barbara, California; Indian Institute for Science Education Research (IISER); and National Chemical Laboratories, Pune, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855341PMC
December 2013

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Cancer Cell 2013 Dec;24(6):751-65

Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2013.10.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917315PMC
December 2013

Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.

Cancer Prev Res (Phila) 2009 Sep 8;2(9):792-9. Epub 2009 Sep 8.

Department of Obstetrics and Gynecology-Center forIntegrative Science, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758654PMC
September 2009

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.

Cell Cycle 2007 Nov 6;6(21):2585-90. Epub 2007 Aug 6.

The Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cc.6.21.4845
Publisher Site
http://dx.doi.org/10.4161/cc.6.21.4845DOI Listing
November 2007

Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.

Proc Natl Acad Sci U S A 2006 Nov 6;103(46):17426-31. Epub 2006 Nov 6.

Pediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0607959103
Publisher Site
http://dx.doi.org/10.1073/pnas.0607959103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859945PMC
November 2006

Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer.

Cancer Res 2006 Mar;66(5):2527-31

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-4063DOI Listing
March 2006

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Nat Med 2005 Jan 26;11(1):63-70. Epub 2004 Dec 26.

Center for Cancer Research, Massachusetts Institute of Technology, 40 Ames Street, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nm1173
Publisher Site
http://dx.doi.org/10.1038/nm1173DOI Listing
January 2005

c-CBL is not required for leukemia induction by Bcr-Abl in mice.

Oncogene 2003 Dec;22(55):8852-60

Department of Cell and Developmental Biology, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206892DOI Listing
December 2003